Dishman Carbogen Amcis Hits New 52-Week High Amid Strong Buying Momentum
Dishman Carbogen Amcis Ltd is experiencing notable buying interest, with the stock achieving a new 52-week high and significant gains over the past week and month. Its performance has consistently surpassed the broader market, reflecting strong upward momentum and robust investor interest in the pharmaceuticals and biotechnology sector.
Dishman Carbogen Amcis Ltd is witnessing significant buying activity, with the stock rising by 5.00% today, contrasting sharply with the Sensex's decline of 0.13%. Over the past week, the stock has gained 17.90%, while the Sensex has only increased by 0.90%. This trend continues over a month, with Dishman Carbogen Amcis up 19.35% compared to the Sensex's 1.49% rise.The stock has been on a positive trajectory, marking consecutive gains for the last four days, accumulating a total return of 17.9% during this period. Today, it opened with a gap up of 2.42% and reached an intraday high of Rs 315.15, which also represents a new 52-week high.
Dishman Carbogen Amcis is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong upward momentum. The stock's performance has significantly outpaced the broader market, suggesting robust buyer interest, potentially driven by favorable market conditions or company-specific developments within the pharmaceuticals and biotechnology sector.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
